On the basis of these data, in vivo investigations are ongoing to examine the effect of vaccination/active immunization with the hybrid peptide on inducing anti-tumor effects in a mouse model with syngeneic tumors expressing Her-2/neu [101]. The gene discussed is ERBB2; the disease is neoplasm.